Skip to content
Bored Studies
RecruitingAccepts healthy volunteers

Improving Maternal Sleep and Mental Health

University of Colorado, Colorado Springs · with University of Virginia, Weill Medical College of Cornell University · NCT06544941

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18–45 · Women only
Healthy volunteers
Accepted
Study type
Interventional · Not applicable
Target enrollment
342
US sites recruiting
1
Study start
January 15, 2025
Record last updated
February 10, 2025

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

The goal of this clinical trial is to test the effectiveness of a Smart Bassinet to prevent/mitigate postpartum mood disorders by augmenting maternal sleep and/or enhancing infant sleep. The investigators will conduct a 2-arm randomized controlled trial (RCT) to compare infant and maternal sleep of infants who use a smart bassinet (SB) or a standard commercially available bassinet (Halo Bassinest Swivel Sleeper 3.0) (usual/traditional care (TAU)). After confirmation of eligibility, participants (N = 342) will randomly be assigned to either the SB or TAU. The investigators hypothesize that use of the SB will be associated with better infant and maternal sleep over a 6-month period, and these mothers will report fewer depressive and anxiety symptoms across the postpartum. The main question[s] it aims to answer [is/are]:

Aim 1: Determine the effect of the SB on infant sleep and maternal sleep. [primary hypothesis or outcome measure 2]? Aim 2: Determine the effect of the SB on maternal postpartum depressive symptoms and evaluate the model that the association between the SB and postpartum depressive symptoms is mediated by both infant and maternal sleep Aim 3: Compare trajectory of immune system function from late pregnancy through postpartum between PPD and non-PPD and between SB and TAU groups Exploratory Aim. Evaluate whether the elevated risk demonstrated by previously identified PPD epigenetic biomarkers at the TTC9B and HP1BP3 genes can be modified by using a SB. The investigators hypothesize that the elevated risk will be reduced in the SB condition compared to TAU.

Military-affiliated pregnant women will be recruited from across the US via social media and advertising. Monthly online questionnaires will be completed by the mother. Objective sleep data will be collected monthly using an actigraph for 1-week from both mother and baby. Blood samples for assay of inflammatory markers will be collected at enrollment, 3- and 6- months postpartum.

Being studied: Smart Bassinet; HALO

Conditions: Postpartum Depression; Postpartum Anxiety; Sleep Disturbance; Infant Behavior; Maternal Behavior; Inflammation; Military Family

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Pregnant women with a singleton gestation who have a military affiliation
  • Ages 18-45 years
  • Ability to communicate during the screening process
  • Access to a computer, smart phone or tablet with internet service
  • Willing to use bassinet they are randomized to
  • Willing to travel to a local Quest for blood draw

Exclusion Criteria

  • Presence of depression assessed over the phone using the Structured Clinical Interview for DSM Disorders - Clinical Version, Mood Disorders Section (SCID-I). Current active suicidal ideation, medical or psychiatric instability, or active substance abuse or dependence during the last 90 days. Since this is a study about risk for recurrent PPMD, actively depressed women will be excluded.
  • Plans to co-sleep with infant. The goal is to compare two bassinets; therefore co-sleeping would prohibit extensive use of a bassinet.
  • Under the age of 18 years or > 45 years. The goal is to include women of childbearing age.
  • Multiple gestations, Type 1 diabetes, congenital fetal anomalies. Women with these factors will likely have major disruption of sleep, require 2 bassinets, or a disrupted home life. These would skew the data and make interpretations and comparisons difficult.
  • Tobacco use (current). Smoking is associated with poor sleep and inflammation.
  • Self-reported, untreated comorbid sleep disorders including narcolepsy, periodic leg movement disorder, and/or obstructive sleep apnea. These disorders contribute to poor sleep and often require medications for treatment.
  • Current use of psychotropic or sleep medications. These are associated with altered sleep and inflammation.

Recruiting US locations

  • University of Colorado Colorado Springs

    Colorado Springs, CO 80918

    Site contact: Michele L Okun, Ph.D. · 412-302-8030 · mokun@uccs.edu

Study contacts (from the official record)

  • Michele L Okun, Ph.D. · 412-302-8030 · mokun@uccs.edu
All sleep studies in Colorado →
Improving Maternal Sleep and Mental Health (NCT06544941) | Bored Studies